David Baltimore

Q: What Schools Are Affiliated With David Baltimore

David Baltimore is affiliated with the following schools: Harvard University, Massachusetts Institute of Technology, California Institute of Technology, University of Oxford, Rockefeller University, Cornell University, Albert Einstein College of Medicine, Uniformed Services University of the Health Sciences, Thomas Jefferson University, Swarthmore College, McGill University, University of California, Los Angeles

David Baltimore's AcademicInfluence.com Rankings

Biology

#17

World Rank

#35

Historical Rank

#10

USA Rank

Virology

World Rank

Historical Rank

USA Rank

Molecular Biology

World Rank

Historical Rank

USA Rank

biology Degrees

Why Is David Baltimore Influential?

(Suggest an Edit or Addition)

Areas of Specialization: Microbiology
David Baltimore is director of the Joint Center for Translational Medicine and President Emeritus and Robert Andrews Milliken Professor of Biology at the California Institute of Technology. He earned a bachelor’s degree from Swarthmore College and a PhD in biology from the Massachusetts Institute of Technology, where he also conducted his postdoctoral research on virus replication.

His research has produced remarkable contributions to cancer research, biotechnology, recombinant DNA research virology, and immunology. In 1975, he shared the Nobel Prize for Physiology or Medicine with Howard Temin and Renato Dulbecco, for their work on interactions between the genetic material contained in the cell and tumor viruses. Reverse transcriptase was found to be an enzyme that can cause cell transcription — or replication of their genomes.

After receiving the Nobel Prize, Baltimore moved into immunology and virology, which led to his work on Abelson murine leukemia virus, lymphocyte differentiation, and the use of tyrosine as a phosphoacceptor.

He is a co-founder of the Whitehead Institute of Biomedical Research which has arisen to international prominence and is considered a crucial partner for the Human Genome Project. From 1997 to 2005, he served as president of the California Institute of Technology, during which time he also received the National Medal of Science from President Bill Clinton.

Academic Website

Featured in Top Influential Biologists Today

According to Wikipedia, David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is President Emeritus and Distinguished Professor of Biology at the California Institute of Technology , where he served as president from 1997 to 2006. He also served as the director of the Joint Center for Translational Medicine, which joined Caltech and UCLA in a program to translate basic scientific discoveries into clinical realities. He also formerly served as president of Rockefeller University from 1990 to 1991, founder and director of the Whitehead Institute of Biomedical Research from 1982 to 1990, and was president of the American Association for the Advancement of Science in 2007.

(See a Problem?)

David Baltimore's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses (2006) (3777)
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death (1996) (2984)
NF-κB: Ten Years After (1996) (2938)
Multiple nuclear factors interact with the immunoglobulin enhancer sequences (1986) (2488)
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins (1989) (2387)
Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. (1990) (2241)
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors (2002) (2033)
I kappa B: a specific inhibitor of the NF-kappa B transcription factor. (1988) (1869)
MicroRNA-155 is induced during the macrophage inflammatory response (2007) (1839)
Production of high-titer helper-free retroviruses by transient transfection. (1993) (1756)
An inducible transcription factor activates expression of human immunodeficiency virus in T cells (1987) (1747)
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence (1989) (1736)
Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of RNA Tumour Viruses (1970) (1716)
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus (1983) (1657)
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation (2002) (1648)
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism (1986) (1522)
Physiological and pathological roles for microRNAs in the immune system (2010) (1486)
RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. (1990) (1442)
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB (1995) (1414)
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor (1990) (1406)
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control (1989) (1378)
The “initiator” as a transcription control element (1989) (1372)
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses (1995) (1295)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology (2017) (1215)
Identification of a ten-amino acid proline-rich SH3 binding site. (1993) (1161)
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. (1996) (1126)
The V(D)J recombination activating gene, RAG-1 (1989) (1125)
MicroRNAs: new regulators of immune cell development and function (2008) (1112)
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes (1998) (1091)
Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB" (1990) (1032)
Modular binding domains in signal transduction proteins (1995) (990)
Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor (1988) (982)
ATR disruption leads to chromosomal fragmentation and early embryonic lethality. (2000) (972)
The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. (1999) (927)
NF-kappa B: ten years after. (1996) (903)
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. (2002) (893)
Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. (1996) (888)
Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses (2010) (872)
MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. (2010) (853)
The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. (1986) (839)
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes (1986) (838)
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo (1991) (830)
Inositol phosphatase SHIP1 is a primary target of miR-155 (2009) (819)
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice (2011) (818)
microRNA regulation of inflammatory responses. (2012) (795)
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder (2008) (777)
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles (1996) (765)
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 (2002) (750)
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. (1995) (746)
Chimeric Nucleases Stimulate Gene Targeting in Human Cells (2003) (740)
Ordered rearrangement of immunoglobulin heavy chain variable region segments. (1984) (721)
A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B all (1990) (706)
Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal (1990) (705)
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. (1986) (689)
The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. (1988) (677)
Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis (1997) (660)
Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. (1982) (656)
Cloned poliovirus complementary DNA is infectious in mammalian cells. (1981) (655)
Defective Viral Particles and Viral Disease Processes (1970) (642)
Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. (1998) (623)
Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins (1991) (616)
Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines (1984) (611)
Immunoglobulin gene transcription is activated by downstream sequence elements (1983) (608)
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides (1993) (608)
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance (2010) (608)
Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a γ2a variable region (1981) (603)
Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. (1988) (600)
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression (1989) (593)
Proline‐rich (PxxP) motifs in HIV‐1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down‐regulation of CD4. (1995) (585)
Achieving Stability of Lipopolysaccharide-Induced NF-κB Activation (2005) (576)
NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase (1999) (572)
A prudent path forward for genomic engineering and germline gene modification (2015) (565)
Expression of animal virus genomes. (1971) (563)
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation (1997) (557)
A detailed model of reverse transcription and tests of crucial aspects (1979) (550)
Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow (1998) (548)
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes (1986) (543)
Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells (1984) (528)
A functional ribonucleoprotein complex forms around the 5′ end of poliovirus RNA (1990) (524)
DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide (1991) (524)
Antibody-based Protection Against HIV Infection by Vectored ImmunoProphylaxis (2011) (522)
Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′‐end of viral RNA. (1993) (518)
Reduction of caveolin and caveolae in oncogenically transformed cells. (1995) (516)
Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. (1999) (513)
Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. (2003) (513)
Circuitry of nuclear factor κB signaling (2006) (512)
Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. (1992) (504)
Regulation of the NF-?B/rel transcription factor and I?B inhibitor system (1993) (493)
Involvement of CRAF1, a relative of TRAF, in CD40 signaling (1995) (489)
MicroRNAs as regulatory elements in immune system logic (2016) (488)
The mechanism of RNA recombination in poliovirus (1986) (483)
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. (1981) (482)
The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules (2009) (477)
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy (2011) (476)
Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. (1994) (474)
Mammalian Ryk Is a Wnt Coreceptor Required for Stimulation of Neurite Outgrowth (2004) (472)
Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ ends (1980) (472)
Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. (1995) (469)
Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. (1987) (468)
Circuitry of nuclear factor kappaB signaling. (2006) (457)
NF-κB functions in synaptic signaling and behavior (2003) (455)
The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. (1993) (453)
Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor (1990) (438)
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine (1980) (438)
A putative modular domain present in diverse signaling proteins (1993) (431)
Dual roles of ATM in the cellular response to radiation and in cell growth control. (1996) (431)
Autoproteolytic activation of pro-caspases by oligomerization. (1998) (427)
Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription (1989) (426)
Organization and reorganization of immunoglobulin genes in A-MuLV-transformed cells: Rearrangement of heavy but not light chain genes (1981) (423)
Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation (1998) (417)
Gene conversion: Some implications for immunoglobulin genes (1981) (416)
The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization (1989) (416)
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA (1980) (413)
The involvement of NF-κB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction (1989) (408)
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase (1981) (404)
Interleukin 3-dependent survival by the Akt protein kinase. (1997) (399)
NF-κB Activation: The IκB Kinase Revealed? (1997) (393)
RNA-directed DNA synthesis and RNA tumor viruses. (1972) (393)
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986. 46: 705-716. (2006) (388)
Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. (1990) (388)
Two Pathways to NF-κB (2002) (384)
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. (1989) (377)
Genetic analysis of NF‐κB/Rel transcription factors defines functional specificities (2003) (376)
Identification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, Dok (1997) (376)
An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers (1991) (374)
NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies (2011) (373)
One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers (2004) (370)
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. (1992) (365)
MicroRNAs and immunity: tiny players in a big field. (2007) (363)
Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency (1990) (358)
MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways (2013) (350)
The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. (1988) (350)
The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. (1991) (348)
Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. (1970) (345)
Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. (1998) (342)
An inducible transcription factor activates expression of human immunodeficiency virus in T cells (1990) (342)
Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes. (1975) (339)
B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. (1996) (338)
Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. (2000) (338)
Polypeptide cleavages in the formation of poliovirus proteins. (1968) (336)
Our genome unveiled (2001) (330)
NF-kappa B functions in synaptic signaling and behavior. (2003) (330)
Standardized and simplified nomenclature for proteins common to all retroviruses (1988) (326)
The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. (1993) (325)
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. (1989) (324)
Modelling T-cell memory by genetic marking of memory T cells in vivo (1999) (319)
Achieving stability of lipopolysaccharide-induced NF-kappaB activation. (2005) (319)
Signalling through SH2 and SH3 domains. (1993) (319)
Heme-Mediated SPI-C Induction Promotes Monocyte Differentiation into Iron-Recycling Macrophages (2014) (318)
Summary statement of the Asilomar conference on recombinant DNA molecules. (1975) (309)
Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus. (1977) (309)
Intracellular immunization (1988) (305)
Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription (1991) (304)
Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. (1994) (303)
Further evidence on the formation of poliovirus proteins. (1970) (303)
MicroRNA-125b Potentiates Macrophage Activation (2011) (298)
Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains. (1990) (295)
Targeted Mutation of TNF Receptor I Rescues the RelA-Deficient Mouse and Reveals a Critical Role for NF-κB in Leukocyte Recruitment1 (2001) (292)
Retroviral Expression in Embryonic Stem Cells and Hematopoietic Stem Cells (2000) (292)
Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. (1998) (291)
An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity (1987) (289)
TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. (1996) (289)
Radiation-induced Assembly of Rad51 and Rad52 Recombination Complex Requires ATM and c-Abl* (1999) (288)
Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo (1992) (287)
Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. (1994) (285)
The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity [published erratum appears in J Cell Biol 1994 Mar;124(5):865] (1994) (285)
The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system (1991) (280)
HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus (1989) (279)
Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. (1990) (279)
MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output (2010) (278)
miR-146a controls the resolution of T cell responses in mice (2012) (276)
Neuronal pp60c-src contains a six-amino acid insertion relative to its non-neuronal counterpart. (1987) (273)
A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus (1976) (272)
Physiological functions for brain NF-κB (2005) (269)
Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. (1968) (262)
Introduction of a μ immunoglobulin gene into the mouse germ line: Specific expression in lymphoid cells and synthesis of functional antibody (1984) (261)
Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. (1996) (260)
Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. (1993) (259)
Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. (1991) (256)
Proline-rich sequences that bind to Src homology 3 domains with individual specificities. (1995) (256)
The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner (1993) (255)
Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. (1980) (254)
Differentiation requires continuous regulation (1991) (253)
N‐terminal mutations activate the leukemogenic potential of the myristoylated form of c‐abl. (1989) (253)
Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. (1989) (252)
Alternative 5′ exons in c-abl mRNA (1986) (247)
Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin. (1996) (246)
Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. (1987) (245)
Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. (1988) (244)
Retroviruses and Retrotransposons: The role of reverse transcription in shaping the eukaryotic genome (1985) (243)
Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. (2014) (238)
MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. (2010) (237)
Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study. (1978) (235)
Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. (1988) (235)
A family of unusually spliced biologically active transcripts encoded by a Drosophila clock gene (1987) (231)
In vitro transformation of lymphoid cells by Abelson murine leukemia virus. (1975) (227)
Severe B Cell Deficiency in Mice Lacking the Tec Kinase Family Members Tec and Btk (2000) (227)
Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance (2010) (225)
Defective Interfering Animal Viruses (1977) (225)
Regulation of NF-κB activity through lysine monomethylation of p65 (2009) (224)
CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef (1996) (224)
The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. (1991) (223)
Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus (1982) (222)
Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression (1990) (221)
Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element. (1988) (221)
Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. (1997) (220)
The Homeodomain Region of Rag-1 Reveals the Parallel Mechanisms of Bacterial and V(D)J Recombination (1996) (218)
CARD11 mediates factor‐specific activation of NF‐κB by the T cell receptor complex (2002) (218)
Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses (1994) (216)
Protein is linked to the 5' end of poliovirus RNA by a phosphodiester linkage to tyrosine. (1978) (215)
Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells. (1978) (215)
Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector (1987) (213)
Essential Role for STAT5 Signaling in CD25+CD4+ Regulatory T Cell Homeostasis and the Maintenance of Self-Tolerance1 (2003) (211)
The mouse c-abl locus: Molecular cloning and characterization (1984) (211)
Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. (1991) (211)
Terminal deoxynucleotidyl transferase in a case of childhood acute lymphoblastic leukemia. (1973) (208)
5'-terminal structure of poliovirus polyribosomal RNA is pUp. (1976) (205)
Engineered lentivector targeting of dendritic cells for in vivo immunization (2008) (205)
MicroRNAs, new effectors and regulators of NF‐κB (2012) (204)
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes (2017) (203)
Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants (1991) (202)
Broadly neutralizing antibodies abrogate established hepatitis C virus infection (2014) (202)
HIV-1 Directly Kills CD4+ T Cells by a Fas-independent Mechanism (1998) (200)
Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production. (1963) (200)
Activity of multiple light chain genes in murine myeloma cells producing a single, functional light chain (1980) (199)
RNA metabolism of murine leukemia virus: detection of virus-specific RNA sequences in infected and uninfected cells and identification of virus-specific messenger RNA. (1973) (198)
Translation of MuLV and MSV RNAs in nuclease-treated reticulocyte extracts: Enhancement of the gag-pol polypeptide with yeast suppressor tRNA (1978) (197)
EVOLUTION OF RNA VIRUSES (1980) (197)
Multiple immunoglobulin heavy-chain gene transcripts in Abelson murine leukemia virus-transformed lymphoid cell lines (1982) (193)
Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus (1979) (190)
SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. (1994) (190)
Is terminal deoxynucleotidyl transferase a somatic mutagen in lymphocytes? (1974) (189)
Patterns of macromolecular synthesis in normal and virus-infected mammalian cells. (1962) (189)
RAG-1 interacts with the repeated amino acid motif of the human homologue of the yeast protein SRP1. (1994) (189)
One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. (2004) (188)
Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. (2000) (188)
Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase (1994) (187)
Rel-associated pp40: an inhibitor of the rel family of transcription factors. (1991) (186)
Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma (2014) (183)
Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. (2008) (183)
The inhibitory ankyrin and activator Rel proteins (1992) (182)
Ribonucleic Acid Synthesis of Vesicular Stomatitis Virus (1969) (182)
Primer requirement and template specificity of the DNA polymerase of RNA tumor viruses. (1971) (182)
Poliovirus-specific primer-dependent RNA polymerase able to copy poly(A). (1977) (182)
The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. (1991) (181)
Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50 (1980) (178)
B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits (1991) (176)
Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus (1977) (175)
Two pathways to NF-kappaB. (2002) (174)
The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia (1987) (172)
Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. (1994) (172)
Phosphotyrosine-containing proteins isolated by affinity chromatography with antibodies to a synthetic hapten (1981) (172)
Enhanced: The Need for a Global HIV Vaccine Enterprise (2003) (168)
Formation of disulphide-linked µ2ω2 tetramers in pre-B cells by the 18K ω-immunoglobulin light chain (1987) (167)
In vitro synthesis of DNA complementary to rabbit reticulocyte 10S RNA. (1972) (167)
Inhibition of translation by poliovirus: inactivation of a specific initiation factor. (1978) (166)
Stable expression of immunoglobulin gene V(D)J recombinase activity by gene transfer into 3T3 fibroblasts (1988) (166)
Relationship of retrovirus polyprotein cleavages to virion maturation studied with temperature-sensitive murine leukemia virus mutants (1978) (165)
Physiological functions for brain NF-kappaB. (2005) (164)
Deletion of the Igκ Light Chain Intronic Enhancer/Matrix Attachment Region Impairs but Does Not Abolish VκJκ Rearrangement (1996) (164)
Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity. (2012) (163)
Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. (2009) (162)
Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma. (1978) (162)
Efficient Gene Targeting Mediated by Adeno-Associated Virus and DNA Double-Strand Breaks (2003) (162)
Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates (2007) (162)
An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses (2017) (162)
Localization of the Major NF-κB-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs* (1997) (160)
The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. (1989) (160)
An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis (1988) (159)
Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. (2006) (156)
The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects. (1999) (156)
High frequency of aberrant expression of moloney murine leukemia virus in clonal infections (1978) (156)
E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice (1993) (156)
A transgenic immunoglobulin Mu gene prevents rearrangement of endogenous genes (1985) (156)
Targeting lentiviral vectors to specific cell types in vivo. (2006) (155)
Poliovirus mutant that does not selectively inhibit host cell protein synthesis (1985) (155)
A novel, inducible and T cell‐specific enhancer located at the 3′ end of the T cell receptor alpha locus. (1989) (154)
Purification and properties of poliovirus double-stranded ribonucleic acid. (1966) (153)
Dispensable sequence motifs in the RAG-1 and RAG-2 genes for plasmid V(D)J recombination. (1993) (150)
Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A (2012) (150)
Engineering poliovirus as a vaccine vector for the expression of diverse antigens. (1994) (149)
Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs (1985) (148)
Three-dimensional solution structure of the src homology 2 domain of c-abl (1992) (148)
The NF‐kappa B p50 precursor, p105, contains an internal I kappa B‐like inhibitor that preferentially inhibits p50. (1992) (147)
Aspects of the synthesis of poliovirus RNA and the formation of virus particles. (1966) (146)
Interaction of HeLa cell proteins with RNA. (1970) (146)
The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. (1987) (146)
Tumor viruses: 1974. (1975) (145)
Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus (1977) (144)
Asilomar conference on recombinant DNA molecules. (1975) (144)
In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of moloney murine leukemia virus (1979) (144)
Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules. (1970) (143)
αβ lineage-specific expression of the α T cell receptor gene by nearby silencers (1989) (143)
Activation of the Transcriptional Function of the NF-κB Protein c-Rel by O-GlcNAc Glycosylation (2013) (143)
Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation (1983) (142)
Ordered transcription of RNA tumor virus genomes. (1976) (141)
DNA elements are asymmetrically joined during the site-specific recombination of kappa immunoglobulin genes. (1985) (141)
ATM and RPA in meiotic chromosome synapsis and recombination (1997) (141)
Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. (2004) (140)
The poliovirus replication complex: Site for synthesis of poliovirus RNA☆ (1967) (139)
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses (1973) (139)
The Pathway to a Universal Influenza Vaccine. (2017) (138)
Collagen: The Fibrous Proteins of the Matrix (2000) (138)
HIV's evasion of the cellular immune response (1999) (137)
Alternative mRNA splicing in cancer immunotherapy (2019) (137)
Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes (2002) (137)
Immunoglobulin heavy-chain expression and class switching in a murine leukaemia cell line (1982) (137)
MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice (2013) (135)
Effect of Fv-1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. (1976) (134)
Molecular basis of a mouse strain-specific anti-hapten response (1983) (133)
Defective Interfering Particles of Poliovirus I. Isolation and Physical Properties (1971) (133)
Generation of mature T cells from human hematopoietic stem/progenitor cells in artificial thymic organoids (2017) (132)
Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. (1994) (131)
Two regulatory elements for immunoglobulin kappa light chain gene expression. (1984) (131)
Defective interfering particles of poliovirus. II. Nature of the defect. (1973) (130)
Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis (1977) (129)
IκBβ acts to both inhibit and activate gene expression at different stages of the inflammatory response (2010) (128)
The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. (1987) (127)
Nomenclature of eukaryotic DNA polymerases (1975) (127)
Broad protection against influenza infection by vectored immunoprophylaxis in mice (2013) (126)
Blast crisis in a murine model of chronic myelogenous leukemia. (1991) (126)
Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor. (1989) (126)
Genetic complementation among poliovirus mutants derived from an infectious cDNA clone (1986) (125)
Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line (1986) (125)
The combined absence of NF-κB1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells (2002) (124)
Isolation of poliovirus 2C mutants defective in viral RNA synthesis (1988) (124)
Anthracyclines induce DNA damage response-mediated protection against severe sepsis. (2013) (123)
Molecular cloning and characterization of hepatitis A virus cDNA. (1983) (123)
Structure of the poliovirus replicative intermediate RNA. (1968) (123)
Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. (2005) (122)
A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product (1979) (122)
p50–NF-κB Complexes Partially Compensate for the Absence of RelB: Severely Increased Pathology in p50− /− relB− /−Double-knockout Mice (1997) (121)
Selective expression of RAG-2 in chicken B cells undergoing immunoglobulin gene conversion (1991) (121)
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase (1971) (120)
Analysis of a 5′ leader sequence on murine leukemia virus 21S RNA: Heteroduplex mapping with long reverse transcriptase products (1978) (119)
Binding of Vav to Grb2 through dimerization of Src homology 3 domains. (1994) (119)
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy. (2013) (119)
Isopycnic Separation of Subcellular Components from Poliovirus-Infected and Normal HeLa Cells (1968) (118)
Murine terminal deoxynucleotidyl transferase: cellular distribution and response to cortisone (1975) (117)
A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity. (1980) (117)
Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in mediating allergy and antihelminth immunity (2014) (116)
Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells. (1980) (116)
Dependence of the activity of the poliovirus replicase on a host cell protein (1980) (116)
A human cell factor is essential for HIV‐1 Rev action. (1990) (116)
Circular forms of Uukuniemi virion RNA: an electron microscopic study (1977) (116)
Virus-Specific Double-Stranded RNA in Poliovirs-Infected Cells (1964) (115)
Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. (1990) (115)
NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity. (1988) (115)
Distinct factors bind to apparently homolgous sequences in the immunoglobulin heavy-chain enhancer (1986) (115)
Requirement for the NF-κB Family Member RelA in the Development of Secondary Lymphoid Organs (2002) (115)
Regulation of monocyte functional heterogeneity by miR-146a and Relb. (2012) (114)
Expression of animal virus genomes (1971) (114)
Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence (1983) (114)
Effect of Pactamycin on Synthesis of Poliovirus Proteins: a Method for Genetic Mapping (1971) (114)
Covalently linked RNA-DNA molecule as initial product of RNA tumour virus DNA polymerase. (1971) (112)
Separate lineages of T cells expressing the αβ and γδ receptors (1989) (112)
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission (2012) (111)
Terminal deoxynucleotidyl transferase is found in prothymocytes (1976) (111)
The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth (1997) (110)
Translation in mammalian cells of a gene linked to the poliovirus 5' noncoding region. (1988) (109)
Essential roles of the κ light chain intronic enhancer and 3′ enhancer in κ rearrangement and demethylation (2002) (109)
Requirement of 3'-terminal poly(adenylic acid) for the infectivity of poliovirus RNA. (1974) (109)
Somatic variants of murine immunoglobulin λ light chains (1982) (109)
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. (2009) (109)
An intermediate in the synthesis of poliovirus RNA. (1966) (108)
NF-kappaB activation: the I kappaB kinase revealed? (1997) (108)
A NEW RIBONUCLEIC ACID POLYMERASE APPEARING AFTER MENGOVIRUS INFECTION OF L-CELLS. (1963) (108)
Quantitation of avian RNA tumor virus reverse transcriptase by radioimmunoassay (1975) (108)
Identification of a protein linked to nascent poliovirus RNA and to the polyuridylic acid of negative-strand RNA (1978) (107)
Functional analysis of the TAN-1 gene, a human homolog of Drosophila notch. (1994) (106)
The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. (1989) (106)
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. (1985) (106)
Translation of murine leukemia virus RNA in cell-free systems from animal cells (1976) (105)
The effect of Mengovirus infection on the activity of the DNA-dependent RNA polymerase of L-cells. (1962) (104)
Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2. (1995) (103)
Involvement of p53 and p21 in Cellular Defects and Tumorigenesis in Atm−/− Mice (1998) (103)
Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells (2011) (103)
Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins. (1996) (103)
Localization of two cellular forms of the vesicular stomatitis viral glycoprotein (1977) (101)
Poliovirus Polyuridylic Acid Polymerase and RNA Replicase Have the Same Viral Polypeptide (1979) (100)
Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. (1997) (100)
Molecular evolution of the vertebrate immune system. (1994) (99)
Depletion of the predominant B-cell population in immunoglobulin µ heavy-chain transgenic mice (1987) (99)
Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy-chain promoter in vitro. (1988) (99)
Isolation of amplified DNA sequences from IMR-32 human neuroblastoma cells: facilitation by fluorescence-activated flow sorting of metaphase chromosomes. (1983) (98)
Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface (1979) (98)
Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation. (1999) (97)
Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. (1992) (97)
Intramolecular integration within Moloney murine leukemia virus DNA (1981) (96)
Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor. (1995) (96)
An enzymatic activity in uninfected cells that cleaves the linkage between poliovirion RNA and the 5′ terminal protein (1978) (96)
An intragenic revertant of a poliovirus 2C mutant has an uncoating defect (1990) (95)
Multiple differences between the nucleic acid sequences of the IgG2aa and IgG2ab alleles of the mouse. (1981) (95)
Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase (reverse transcriptase). (1975) (94)
Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. (1993) (93)
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection (2015) (92)
Preliminary data on a virus-specific enzyme system responsible for the synthesis of viral RNA. (1962) (92)
Absence of Interference During High-Multiplicity Infection by Clonally Purified Vesicular Stomatitis Virus (1971) (92)
Genome-linked protein VPg of poliovirus is present as free VPg and VPg-pUpU in poliovirus-infected cells. (1983) (91)
The effect of helper virus on Abelson virus-induced transformation of lymphoid cells (1978) (91)
NF-κB is 25 (2011) (91)
The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2 (1990) (90)
Vectored ImmunoProphylaxis Protects Humanized Mice from Mucosal HIV Transmission (2012) (90)
Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5' noncoding region (1990) (90)
Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. (1996) (90)
Functional TCR T cell screening using single-cell droplet microfluidics. (2018) (90)
T cell antigen discovery via trogocytosis (2019) (89)
Synthesis of Long, Representative DNA Copies of the Murine RNA Tumor Virus Genome (1976) (89)
Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory Stimuli are Altered with Age (2017) (89)
Dissecting Fas signaling with an altered-specificity death-domain mutant: requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation. (1999) (89)
The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region (1993) (89)
Functional commitment to helper T cell lineage precedes positive selection and is independent of T cell receptor MHC specificity. (1994) (88)
Negative regulation of immunoglobulin kappa light-chain gene transcription by a short sequence homologous to the murine B1 repetitive element (1993) (88)
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. (1991) (87)
A poliovirus temperature-sensitive RNA synthesis mutant located in a noncoding region of the genome. (1986) (87)
Phorbol-ester-induced activation of the NF-kappa B transcription factor involves dissociation of an apparently cytoplasmic NF-kappa B/inhibitor complex. (1988) (86)
The MicroRNA-132 and MicroRNA-212 Cluster Regulates Hematopoietic Stem Cell Maintenance and Survival with Age by Buffering FOXO3 Expression. (2015) (84)
Complementation of V(D)J recombination deficiency in RAG-1(-/-) B cells reveals a requirement for novel elements in the N-terminus of RAG-1. (1997) (84)
DNA polymerase activity from two temperature-sensitive mutants of Rous sarcoma virus is thermolabile (1974) (84)
Domain-dependent Function of the rasGAP-binding Protein p62Dok in Cell Signaling* (2001) (83)
High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees (1993) (83)
3BP‐1, an SH3 domain binding protein, has GAP activity for Rac and inhibits growth factor‐induced membrane ruffling in fibroblasts. (1995) (82)
Chromosomal location of structural genes encoding murine immunoglobulin lambda light chains. Genetics of murine lambda light chains (1981) (82)
Poliovirus replicase: a soluble enzyme able to initiate copying of poliovirus RNA. (1979) (82)
RNA splicing regulates the temporal order of TNF-induced gene expression (2012) (81)
Joining of VK to JK gene segments in a retroviral vector introduced into lymphoid cells (1984) (81)
T cell antigen discovery via Signaling and Antigen presenting Bifunctional Receptors (2019) (81)
Different Molecular Consequences of the 1;19 Chromosomal Translocation in Childhood B - Cell Precursor Acute Lymphoblastic Leukemia (1992) (79)
Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. (2012) (79)
Antibodies against the chemically synthesized genome-linked protein of poliovirus react with native virus-specific proteins (1982) (78)
Dependence of Moloney murine leukemia virus production on cell growth. (1975) (78)
Morphogenesis of Poliovirus II. Demonstration of a New Intermediate, the Proviron (1973) (78)
Expression of an Abelson murine leukemia virus-encoded protein in Escherichia coli causes extensive phosphorylation of tyrosine residues. (1982) (78)
A plasma membrane component able to bind and alter virions of poliovirus type 1: studies on cell-free alteration using a simplified assay. (1977) (77)
Forms of Deoxyribonucleic Acid Produced by Virions of the Ribonucleic Acid Tumor Viruses (1971) (77)
Virus-Like 30S RNA in Mouse Cells (1979) (77)
Analysis of the defects of temperature-sensitive mutants of vesicular stomatitis virus: intracellular degradation of specific viral proteins (1977) (76)
Mechanism of restriction of ecotropic and xenotropic murine leukemia viruses and formation of pseudotypes between the two viruses (1977) (76)
The Human Thioesterase II Protein Binds to a Site on HIV-1 Nef Critical for CD4 Down-regulation* (2000) (75)
Chromatin remodeling directly activates V(D)J recombination. (1999) (75)
Factors affecting cellular tropism of human immunodeficiency virus (1990) (75)
Gene therapy. Intracellular immunization. (1988) (75)
Function of the pre-T-cell receptor alpha chain in T-cell development and allelic exclusion at the T-cell receptor beta locus. (1996) (74)
Somatic mutation gains its place among the generators of diversity (1981) (74)
Association of an endoribonuclease with the avian myeloblastosis virus deoxyribonucleic acid polymerase. (1972) (74)
Regulated expression of an immunoglobulin kappa gene introduced into a mouse lymphoid cell line. (1982) (73)
Structure of the abelson murine leukemia virus genome (1979) (73)
Reconstruction of the 1918 Influenza Virus: Unexpected Rewards from the Past (2012) (73)
IN VITRO SYNTHESIS OF VIRAL RNA BY THE POLIOVIRUS RNA POLYMERASE. (1964) (73)
Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents (1981) (73)
Nomenclature of eukaryotic DNA polymerases. (1975) (73)
Absence of Polymerase Protein in Virions of Alpha-Type Rous Sarcoma Virus (1972) (73)
Mechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses (1991) (72)
Regulation of stress-induced hematopoiesis (2015) (72)
Defective interfering particles of poliovirus. 3. Interference and enrichment. (1973) (72)
In vitro synthesis of infectious DNA of murine leukaemia virus (1977) (72)
Complete translation of poliovirus RNA in a eukaryotic cell-free system. (1975) (72)
Polyadenylic acid on poliovirus RNA. II. poly(A) on intracellular RNAs (1975) (72)
Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells (1981) (71)
Purification of a terminal uridylyltransferase that acts as host factor in the in vitro poliovirus replicase reaction. (1986) (70)
Assignment of the receptor for ecotropic murine leukemia virus to mouse chromosome 5 (1978) (69)
Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus (1977) (69)
Translation of Vesicular Stomatitis Messenger RNA by Extracts from Mammalian and Plant Cells (1974) (69)
5′-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical (1977) (69)
Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1* (2016) (69)
Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. (2002) (68)
The microRNA-212/132 cluster regulates B cell development by targeting Sox4 (2015) (66)
MicroRNAs and hematopoietic cell development. (2012) (66)
Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation (1994) (66)
Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus. (1985) (65)
Inhibition of transcription factor activity by poliovirus (1981) (65)
HIV-1 Messenger RNA in Peripheral Blood Mononuclear Cells as an Early Marker of Risk for Progression to AIDS (1995) (65)
The genome of Uukuniemi virus consists of three unique RNA segments (1977) (64)
In vitro copying of viral positive strand RNA by poliovirus replicase. Characterization of the reaction and its products. (1982) (64)
Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor. (2011) (64)
The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3. (1999) (64)
Increased length of DNA made by virions of murine leukemia virus at limiting magnesium ion concentration (1977) (63)
HIV Vaccines—where are we going? (1998) (63)
The physiology of the NF-κB transcription factor (1991) (62)
Let-7 Suppresses B Cell Activation through Restricting the Availability of Necessary Nutrients. (2018) (62)
Myeloid Cell-Targeted miR-146a Mimic Inhibits NF-kB-Driven Inflammation and Leukemia Progression in Vivo. (2019) (62)
Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice (2014) (62)
Nuclear factor NF‐kappa B can interact functionally with its cognate binding site to provide lymphoid‐specific promoter function. (1988) (62)
Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells (2002) (61)
Transformation of Immature Lymphoid Cells by Abelson Murine Leukemia Virus (1979) (61)
Poliovirus replicase stimulation by terminal uridylyl transferase. (1985) (60)
Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats. (1982) (60)
Transfection of Fibroblasts by Cloned Abelson Murine Leukemia Virus DNA and Recovery of Transmissible Virus by Recombination with Helper Virus (1982) (60)
Cloning of terminal transferase cDNA by antibody screening. (1984) (60)
Synthesis of immunoglobulin mu chain gene products precedes synthesis of light chains during B-lymphocyte development. (1981) (59)
Purification and properties of a HeLa cell enzyme able to remove the 5'-terminal protein from poliovirus RNA. (1980) (59)
[66] Translation of reovirus mRNA, poliovirus RNA, and bacteriophage Qβ RNA in cell-free extracts of mammalian cells (1974) (59)
MENGOVIRUS-INDUCED INHIBITION OF HOST RIBONUCLEIC ACID AND PROTEIN SYNTHESIS. (1963) (59)
Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression (1990) (59)
Dual expression of λ genes in the MOPC-315 plasmacytoma (1981) (58)
HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells (2009) (57)
Mechanism of induction of RNA tumor viruses by halogenated pyrimidines. (1975) (57)
Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood (2019) (57)
The Yin and Yang of microRNAs: leukemia and immunity (2013) (57)
Silencing of the expression of the immunoglobulin kappa gene in non-B cells (1991) (57)
The omega and iota surrogate immunoglobulin light chains. (1988) (57)
Expression of J chain RNA in cell lines representing different stages of B lymphocyte differentiation (1981) (57)
Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes (1979) (56)
RNA-binding protein Lin28 in cancer and immunity. (2016) (56)
Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line (1992) (56)
Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. (1992) (55)
Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation. (1989) (55)
A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase (2011) (55)
Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line (2020) (55)
Lentiviral Vector Delivery of Human Interleukin-7 (hIL-7) to Human Immune System (HIS) Mice Expands T Lymphocyte Populations (2010) (55)
Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase (1984) (55)
The effect of HeLa cell cytoplasm on the rate of sedimentation of RNA. (1966) (54)
Hormone‐conditional transformation by fusion proteins of c‐Abl and its transforming variants. (1993) (54)
Purification of the RNA-directed DNA polymerase from avian myeloblastosis virus and its assay with polynucleotide templates. (1974) (53)
Chromosomal assignment of the endogenous proto-oncogene C-abl. (1982) (53)
Phosphorylation of ribosomal protein S6 on serine after microinjection of the Abelson murine leukemia virus tyrosine-specific protein kinase into Xenopus oocytes. (1985) (52)
MicroRNAs as regulatory elements in immune system logic (2016) (52)
The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase (1985) (51)
32 The Helix-Loop-Helix Motif: Structure and Function (1992) (51)
Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. (2014) (51)
Integrating Cells into Tissues (2000) (50)
Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria. (1985) (50)
Heteroduplex analysis of the nonhomology region between Moloney MuLV and the dual host range derivative HIX virus (1978) (50)
Poliovirus mutant that contains a cold-sensitive defect in viral RNA synthesis (1988) (50)
Frontiers of Life (2001) (49)
The Cellular Immunotherapy Revolution: Arming the Immune System for Precision Therapy. (2019) (49)
Morphogenesis of poliovirus. IV. existence of particles sedimenting at 150S and having the properties of provirion (1977) (49)
Myristoylation and the post-translational acquisition of hydrophobicity by the membrane immunoglobulin heavy-chain polypeptide in B lymphocytes. (1987) (49)
Terminal deoxynucleotidyltransferase. Serological studies and radioimmunoassay. (1976) (48)
Synthesis of a 600-nucleotide-long plus-strand DNA by virions of Moloney murine leukemia virus. (1979) (48)
Viruses, polymerases, and cancer. (1976) (48)
Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes. (1978) (48)
CD4+CD25− T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model1 (2008) (47)
Anti-VPg antibody inhibition of the poliovirus replicase reaction and production of covalent complexes of VPg-related proteins and RNA (1982) (47)
Molecular Cell Biology: An Integrated View of Cells at Work (2000) (47)
T-cell immunotherapy: looking forward. (2014) (47)
Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules (2018) (46)
Discovering NF-kappaB. (2009) (46)
Protein Glycosylation in the ER and Golgi Complex (2000) (46)
Proto-Oncogenes and Tumor-Suppressor Genes (2000) (46)
NUCLEOTIDE SEQUENCES OF HUMAN GLOBIN MESSENGER RNA * (1974) (46)
Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus (1985) (46)
Viruses: Structure, Function, and Uses (2000) (45)
Altered repertoire of endogenous immunoglobulin gene expression in transgenic mice containing a rearranged mu heavy chain gene (1988) (45)
Cell-Cell Adhesion and Communication (2000) (45)
Signal transduction: A cellular rescue team (2000) (44)
Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells. (2013) (44)
As good as it gets? The problem of HIV persistence despite antiretroviral drugs. (2012) (44)
Direction of polymerization by the avian myeloblastosis virus deoxyribonucleic acid polymerase. (1971) (44)
Covalent Linkage Between Ribonucleic Acid Primer and Deoxyribonucleic Acid Product of the Avian Myeloblastosis Virus Deoxyribonucleic Acid Polymerase (1972) (44)
Antibody gene transfer with adeno‐associated viral vectors as a method for HIV prevention (2017) (43)
Exploring the limits of ultrafast polymerase chain reaction using liquid for thermal heat exchange: A proof of principle. (2010) (43)
Genetic evidence that the RAG1 protein directly participates in V(D)J recombination through substrate recognition. (1996) (43)
Localization of the Abelson murine leukemia virus protein in a detergent-insoluble subcellular matrix: architecture of the protein (1981) (43)
Conversion of Danger Signals into Cytokine Signals By Hematopoietic Stem and Progenitor Cells for Regulation of Stress-Induced Hematopoiesis (2014) (43)
Effect of Fv-1 gene product on synthesis of N-tropic and B-tropic murine leukemia viral RNA (1976) (43)
Double-stranded cleavage by cell extracts near recombinational signal sequences of immunoglobulin genes (1984) (43)
v-abl causes hematopoietic disease distinct from that caused by bcr-abl. (1991) (42)
Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. (1993) (42)
Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. (1996) (42)
Interaction of tryptophan tRNA and avian myeloblastosis virus reverse transcriptase: further characterization of the binding reaction. (1977) (42)
The Synthesis and Translation of Poliovirus RNA (1967) (42)
Dimeric 2G12 as a Potent Protection against HIV-1 (2010) (42)
Intracellular Ion Environment and Membrane Electric Potential (2000) (42)
Purification and properties of a host cell protein required for poliovirus replication in vitro. (1982) (41)
In vitro V(D)J recombination: signal joint formation. (1996) (41)
V(D)J recombination is not activated by demethylation of the kappa locus. (2000) (41)
Domain-swapped T cell receptors improve the safety of TCR gene therapy (2016) (41)
MicroRNA-34 a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp 1 (2010) (41)
NF-κB functions in synaptic signaling and behavior (2003) (39)
Cell-to-Cell Signaling: Hormones and Receptors (2000) (39)
Protein synthesis in Escherichia coli extracts programmed by poliovirus RNA. (1970) (39)
B‐Lyl Cells: Immortal Ly‐1 + B Lymphocyte Cell Lines Spontaneously Arising in Murine Splenic Cultures (1986) (39)
Effect of the Fv-1 locus on the titration of murine leukemia viruses (1975) (39)
Synthesis of murine leukemia virus plus strong stop DNA initiates at a unique site. (1982) (39)
Polyadenylic acid on poliovirus RNA IV. Poly(U) in replicative intermediate and double-stranded RNA. (1975) (39)
EHMT1 Protein Binds to Nuclear Factor-κB p50 and Represses Gene Expression* (2012) (39)
Molecular basis of heavy-chain class switching and switch region deletion in an Abelson virus-transformed cell line (1984) (38)
T-cell-specific expression of interleukin 2: evidence for a negative regulatory site. (1988) (38)
The long terminal repeat is not a major determinant of the cellular tropism of human immunodeficiency virus type 1 (1991) (37)
B lymphocyte-specific protein binding near an immunoglobulin kappa-chain gene J segment. (1987) (36)
Epigenetic silencing of miR-125b is required for normal B-cell development. (2018) (35)
Defective Interfering Particles of Poliovirus IV. Mechanisms of Enrichment (1973) (35)
The role of microRNA in nutritional control (2015) (35)
Overview of Neuron Structure and Function (2000) (34)
Dual mechanisms of posttranscriptional regulation of Tet2 by Let-7 microRNA in macrophages (2019) (34)
Inhibition of DNA Binding by NF-κB with Pyrrole-Imidazole Polyamides (2002) (34)
Uncovering the V(D)J recombinase (2004) (33)
Hamster Leukemia Virus: Lack of Endogenous DNA Synthesis and Unique Structure of Its DNA Polymerase (1974) (33)
Neurotransmitters, Synapses, and Impulse Transmission (2000) (33)
Antibodies against a synthetic peptide of the poliovirus replicase protein: reaction with native, virus-encoded proteins and inhibition of virus-specific polymerase activities in vitro (1982) (33)
A butterfly flutters by (1995) (33)
MicroRNA-146a Provides Feedback Regulation of Lyme Arthritis but Not Carditis during Infection with Borrelia burgdorferi (2014) (33)
Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines (1984) (33)
Encoding NF- (cid:1) B temporal control in response to TNF: distinct roles for the negative regulators I (cid:1) B (cid:2) and A20 (2008) (32)
Retraction. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. (1999) (31)
Biosynthesis of murine terminal deoxynucleotidyltransferase. (1980) (31)
Biomembranes: Structural Organization and Basic Functions (2000) (30)
Phosphorylation of the Abelson murine leukemia virus transforming protein (1981) (30)
Erratum: Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes (Proc. Natl. Acad. Sci. USA (June 1991) 88 (5011-5015)) (1992) (30)
Continuing rearrangement of immunoglobulin and T-cell receptor genes in a Ha-ras-transformed lymphoid progenitor cell line. (1987) (30)
The identification of nucleoside triphosphate ends on RNA formed in the RNA polymerase reaction (1965) (30)
Formation of disulphide-linked mu 2 omega 2 tetramers in pre-B cells by the 18K omega-immunoglobulin light chain. (1987) (30)
Viral RNA-dependent DNA polymerase. 1970. (1992) (30)
Sexual preference of apparent gene conversion events in MHC genes of mice (1984) (30)
Viral genetic systems. (1971) (30)
Secondary structure of Src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution. (1992) (30)
Studies on the function of polyadenylic acid on poliovirus RNA (1975) (29)
THE RELATION OF PROTEIN SYNTHESIS TO FORMATION OF POLIOVIRUS RNA POLYMERASE. (1963) (29)
5′-Terminus of Moloney Murine Leukemia Virus 35S RNA Is m7G5′ ppp5′ GmpCp (1976) (29)
Pi, a pre-B-cell-specific enhancer element in the immunoglobulin heavy-chain enhancer. (1993) (29)
DNA Replication, Repair, and Recombination (2000) (29)
Tumor Cells and the Onset of Cancer (2000) (28)
Altered repertoire of endogenous immunoglobulin gene expression in transgenic mice containing a rearranged Mu heavy chain gene (1986) (28)
Cellular latency of human immunodeficiency virus type 1. (1992) (28)
In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences. (1987) (28)
Four murine c-abl mRNAs arise by usage of two transcriptional promoters and alternative splicing. (1988) (27)
Protein Sorting: Organelle Biogenesis and Protein Secretion (2000) (27)
Leukemogenicity of clonal isolates of murine leukemia viruses. (1978) (27)
Oligonucleotide that binds nuclear factor NF-KB acts as a lymphoid-specific and inducible enhancer element ( immunoglobulin c light chain gene / transfection ) (26)
Cytogenetic studies on abelson‐virus‐induced mouse leukemias (1980) (26)
Cell-Cycle Control in Mammalian Cells (2000) (26)
EFFECTS OF PUROMYCIN AND P-FLUOROPHENYLALANINE ON MENGOVIRUS RIBONUCLEIC ACID AND PROTEIN SYNTHESIS. (1963) (26)
Non-viral precision T cell receptor replacement for personalized cell therapy (2022) (26)
Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines (1987) (26)
Oxidation of Glucose and Fatty Acids to CO2 (2000) (25)
Screening procedure for complementation-dependent mutants of vesicular stomatitis virus (1975) (25)
DNA Damage and Repair and Their Role in Carcinogenesis (2000) (25)
Regulation of APC development, immune response, and autoimmunity by Bach1/HO-1 pathway in mice. (2012) (25)
Targeting lentiviral vectors to antigen-specific immunoglobulins. (2008) (25)
Translation of reovirus mRNA, poliovirus RNA and bacteriophage Qbeta RNA in cell-free extracts of mammalian cells. (1974) (24)
Bud13 Promotes a Type I Interferon Response by Countering Intron Retention in Irf7 (2018) (24)
Synthesis of DNA complementary to cellular slime mold messenger RNA by reverse transcriptase. (1974) (24)
Hierarchical Structure of Proteins (2000) (24)
Homeostatic cytokines orchestrate the segregation of CD4 and CD8 memory T-cell reservoirs in mice. (2011) (23)
Identification of the Vesicular Stomatitis Virus Large Protein as a Unique Viral Protein (1973) (23)
Size of murine RNA tumor virus-specific nuclear RNA molecules (1976) (23)
Specific transforming potential of oncogenes encoding protein‐tyrosine kinases. (1985) (23)
Separation of quantitation of intracellular forms of poliovirus RNA by agarose gel electrophoresis (1977) (22)
Isolation and characterization of a mouse cell line containing a defective Moloney murine leukemia virus genome (1979) (22)
The Action Potential and Conduction of Electric Impulses (2000) (22)
The enigma of HIV infection (1995) (22)
GLOBIN MESSENGER RNA IN THE THALASSEMIA SYNDROMES * (1974) (22)
Ribonucleic AcidSynthesis ofVesicular Stomatitis Virus I.Species ofRibonucleic AcidFoundinChinese Hamster OvaryCells Infected withPlaque-forming andDefective Particles (1969) (22)
CHAPTER 19 - Transcriptional regulation of immunoglobulin gene expression (1991) (22)
Morphogenesis of poliovirus III. Formation of Provirion in Cell-Free Extracts (1973) (21)
The recombination activating genes, RAG 1 and RAG 2, are on chromosome 11p in humans and chromosome 2p in mice (2004) (21)
Cloning and analysis of reverse transcript P160 genomes of Abelson murine leukemia virus (1983) (21)
Structure and expression of the Abelson murine leukemia virus genome and its relationship to a normal cell gene. (1980) (21)
Single-molecule analysis of RAG-mediated V(D)J DNA cleavage (2015) (20)
The Dynamics of Actin Assembly (2000) (20)
Mutations: Types and Causes (2000) (20)
Role of the subunits of the avian RNA tumor virus reverse transcriptase. (1975) (20)
Specialized DNA polymerases in lymphoid cells. (1977) (20)
The Three Roles of RNA in Protein Synthesis (2000) (20)
Characterization of endonuclease activities in Moloney murine leukemia virus and its replication-defective mutants (1987) (20)
Photosynthetic Stages and Light-Absorbing Pigments (2000) (20)
The Role of Topoisomerases in DNA Replication (2000) (20)
Processing of rRNA and tRNA (2000) (19)
Overview of the Secretory Pathway (2000) (19)
How biology became an information science (2001) (19)
Separate lineages of T cells expressing the alpha beta and gamma delta receptors. (1989) (19)
Recombinants within the tyrosine kinase region of v-abl and v-src identify a v-abl segment that confers lymphoid specificity (1988) (19)
Retraction: Altered repertoire of endogenous immunoglobulin gene expression in transgenic mice containing a rearranged Mu heavy chain gene (1991) (19)
HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells (2017) (18)
Complementarity between messenger RNA and nuclear RNA from HeLa cells. (1972) (18)
MATE-Seq: microfluidic antigen-TCR engagement sequencing. (2019) (18)
Myosin: The Actin Motor Protein (2000) (18)
Protease bypass of temperature-sensitive murine leukemia virus maturation mutants (1982) (18)
Stimulation of kappa light-chain gene rearrangement by the immunoglobulin mu heavy chain in a pre-B-cell line (1993) (18)
T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable (2018) (18)
The formation of poliovirus proteins. (1969) (18)
17 – Factors Regulating Immunoglobulin-Gene Transcription (1989) (17)
Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice (2016) (17)
Pillars Article: The V(D)J Recombination Activating Gene, RAG-1. Cell 1989. 59: 1035–1048. (2008) (17)
Overview of Membrane Transport Proteins (2000) (17)
Human Embryo Editing: Opportunities and Importance of Transnational Cooperation. (2017) (17)
Letter: Potential biohazards of recombinant DNA molecules. (1974) (17)
Terminal deoxynucleotidyl transferase in normal and neoplastic hematopoietic cells. (1976) (17)
Preparation of peptide-MHC and T-cell receptor dextramers by biotinylated dextran doping. (2017) (16)
A trans-acting protein kinase identified in cells transformed by Abelson murine leukemia virus. (1980) (16)
Osmosis, Water Channels, and the Regulation of Cell Volume (2000) (16)
Overview of the Cell Cycle and Its Control (2000) (16)
Cilia and Flagella: Structure and Movement (2000) (16)
Antibody to a host protein prevents initiation by the poliovirus replicase (1982) (16)
Chronic myelogenous leukemia--the unfolding saga. (1990) (16)
Regulation of Transcription Initiation (2000) (15)
A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses. (2012) (15)
Structure of cloned retroviral circular DNAs: implications for virus integration. (1981) (15)
Polyadenylic acid on poliovirus RNA. III. In vitro addition of polyadenylic acid to poliovirus RNAs (1975) (15)
Production of a discrete, infectious, double-stranded DNA by reverse transcription in virions of Moloney murine leukemia virus. (1979) (15)
DNA Cloning with Plasmid Vectors (2000) (14)
Alpha beta lineage-specific expression of the alpha T cell receptor gene by nearby silencers. (1989) (14)
The terminal deoxynucleotidyltransferase gene is located on human chromosome 10 (10q23----q24) and on mouse chromosome 19. (1986) (14)
The Dynamic Plant Cell Wall (2000) (14)
Poly(A) on mengovirus RNA (1975) (14)
T-Cell Immunotherapy: Looking Forward: T Cell Immunotherapy: Optimizing Trial Design Bethesda, Maryland 10-11 September 2013. (2014) (14)
IN VITRO REPLICATION OF RNA TUMOR VIRUSES (1976) (14)
Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells (2011) (14)
Lack of evidence for VPg priming of poliovirus RNA synthesis in the host factor-dependent in vitro replicase reaction (1986) (14)
The Actin Cytoskeleton (2000) (14)
HIV vaccines: prospects and challenges. (1998) (14)
Virus production by Abelson murine leukemia virus-transformed lymphoid cells (1979) (14)
Disappearing Stem Cells, Disappearing Science (2001) (13)
Use of Mutated Self-Cleaving 2A Peptides as a Molecular Rheostat to Direct Simultaneous Formation of Membrane and Secreted Anti-HIV Immunoglobulins (2012) (13)
Maintenance of Self-Tolerance Regulatory T Cell Homeostasis and the + CD4 + Essential Role for STAT5 Signaling in CD25 (2003) (13)
Transport across Cell Membranes (2000) (13)
Diffusion of Small Molecules across Phospholipid Bilayers (2000) (13)
Receptor-Mediated Endocytosis and the Sorting of Internalized Proteins (2000) (13)
Photon-Induced Near-Field Electron Microscopy of Eukaryotic Cells. (2017) (13)
Receptor Tyrosine Kinases and Ras (2000) (12)
Targeting Lentiviral Vectors to Antigen-Specific Immunoglobulins (2008) (12)
Terminal deoxynucleotidyl transferase in AKR leukemic cells and lack of relation of enzyme activity to cell cycle phase. (1976) (12)
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial (2022) (12)
Properties of the Mengovirus and Poliovirus RNA Polymerases (1963) (12)
A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication (2018) (12)
Picornaviruses are no longer black boxes. (1985) (12)
Separation and quantitation of intracellular forms of poliovirus RNA by agarose gel electrophoresis. (1977) (12)
Cell Motility and Shape II: Microtubules and Intermediate Filaments (2000) (12)
From Plasma Membrane to Nucleus (2000) (12)
Alternative splicing coupled with transcript degradation modulates OAS1g antiviral activity (2019) (11)
Preparation ofSyngeneic TumorRegressor SerumReactive withtheUnique Determinants oftheAbelson Murine Leukemia Virus-Encoded P120Protein attheCellSurface (1979) (11)
PROBES FOR SPECIFIC mRNAS BY SUBTRACTIVE HYBRIDIZATION: ANOMALOUS EXPRESSION OF IMMUNOGLOBULIN GENES1 (1979) (11)
Author Correction: An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses (2018) (11)
Discovery of the Reverse Transcriptase (1995) (11)
Active Transport by ATP-Powered Pumps (2000) (11)
Structure of Nucleic Acids (2000) (11)
MATE-Seq: Microfluidic Antigen-TCR Engagement Sequencing (2019) (11)
Purified bovine NF-kappa B recognizes regulatory sequences in multiple genes expressed during activation of T- and B-lymphocytes. (1989) (11)
A Global Perspective on Science and Technology (2008) (10)
Inhibition of DNA binding by NF-kappa B with pyrrole-imidazole polyamides. (2002) (10)
Dendritic cells efficiently transmit HIV to T Cells in a tenofovir and raltegravir insensitive manner (2018) (10)
Temperature‐sensitive dna polymerase from rous sarcoma virus mutants (1974) (10)
Electron Transport and Oxidative Phosphorylation (2000) (10)
Nucleic Acids, the Genetic Code, and the Synthesis of Macromolecules (2000) (10)
Noncollagen Components of the Extracellular Matrix (2000) (10)
Transport across Epithelia (2000) (10)
Post-Translational Modifications and Quality Control in the Rough ER (2000) (9)
Overview of Extracellular Signaling (2000) (9)
Poliovirus MutantThatDoesNotSelectively Inhibit HostCell Protein Synthesis (1985) (9)
Translation of poliovirus RNA by an E. coli cell-free system. (1969) (9)
Insertion of Membrane Proteins into the ER Membrane (2000) (9)
Isolation and Analysis of Mutants (2000) (9)
In vivo tissue distribution of CD4 lymphocytes in mice determined by radioimmunoscintigraphy with an 111In-labeled anti-CD4 monoclonal antibody. (1996) (9)
A path toward understanding neurodegeneration (2016) (9)
The molecular biology of poliovirus. (1975) (9)
Translocation of Secretory Proteins across the ER Membrane (2000) (8)
The impact of the discovery of oncogenes on cancer mortality rates will come slowly (1987) (8)
vpu , env , and nef . virus type 1 involves independent activities of human T cells with human immunodeficiency CD 4 down-modulation during infection of (1996) (8)
DNA-binding proteins. A butterfly flutters by. (1995) (8)
Nobel lectures in molecular biology, 1933-1975 (1977) (8)
The synthesis of protein by mammalian RNA viruses. In: strategy of the viral genome. (1971) (8)
The Dynamic Cell (2000) (8)
TheImmunoglobulin HeavyChainLocusContains Another B-Cell-Specific 3'Enhancer Close totheotConstant Region (1993) (8)
Purification of Cells and Their Parts (2000) (8)
RNA Polymerase II Transcription-Initiation Complex (2000) (8)
Growth of Animal Cells in Culture (2000) (8)
Nucleotide sequences of human globin messenger RNA. (1980) (8)
Dendritic cell–targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation (2017) (8)
G Protein –Coupled Receptors and Their Effectors (2000) (8)
Kinetic Inference Resolves Epigenetic Mechanism of Drug Resistance in Melanoma (2019) (8)
On Over-Weighting the Bottom Line (2003) (8)
Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells (2012) (8)
Science Over Politics (1999) (8)
Science and the Bush Administration (2004) (8)
Microtubule Dynamics and Associated Proteins (2000) (8)
RNA Processing, Nuclear Transport, and Post-Transcriptional Control (2000) (8)
Joining of V kappa to J kappa gene segments in a retroviral vector introduced into lymphoid cells. (1984) (8)
The ties that bind or benefit (1980) (7)
Processing of Eukaryotic mRNA (2000) (7)
Eukaryotic Transcription Activators and Repressors (2000) (7)
MAP Kinase Pathways (2000) (7)
Identification of 3BP-1 in cDNA expression library by SH3 domain screening. (1995) (7)
RNA-Dependent Synthesis of DNA by Virions of Mouse Leukemia Virus (1970) (7)
Organelles of the Eukaryotic Cell (2000) (7)
ALTERED LOCATION OF PROTEIN SYNTHESIS IN THE CELL AFTER POLIOVIRUS INFECTION. (1963) (7)
Cell Motility and Shape I: Microfilaments (2000) (7)
Correction: An inhibitory domain of-E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers (1991) (7)
Negative Regulation ofImmunoglobulin KappaLight-Chain GeneTranscription bya ShortSequence Homologous totheMurineBiRepetitive Element (1993) (7)
The strategy of RNA viruses. (1974) (7)
Cyclic AMP induces terminal deoxynucleotidyl transferase in immature B cell leukemia lines. (1985) (7)
Molecular Mechanisms of Vesicular Traffic (2000) (6)
The worsening climate for biological research. (1989) (6)
Folding, Modification, and Degradation of Proteins (2000) (6)
Microtubule Dynamics and Motor Proteins during Mitosis (2000) (6)
Ribonucleic AcidPolymerase inVirions ofNewcastle Disease Virus: Comparison withtheVesicular Stomatitis VirusPolymerase (1971) (6)
Mutations that disrupt DNA binding and dimer formation in the E 47 helix-loop-helix protein map to distinct domains ( transcriptional enhancers / E 2 A gene / helix-loop-helix structure ) (6)
A Defense of Atheism (2007) (6)
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System (2018) (6)
Actin and Myosin in Non-muscle Cells (1973) (6)
Checkpoints in Cell-Cycle Regulation (2000) (6)
Emerging Themes in Biology: Hints for the Future (2014) (6)
Substitutions intheProtease (3CPrO) GeneofPoliovirus Can Suppress a Mutation inthe5'Noncoding Region (1990) (6)
Immunoglobulin genes: Inversion for gene construction (1986) (6)
Sequence-dependent dynamics of synthetic and endogenous RSSs in V(D)J recombination (2019) (6)
Mutations Affecting Genome Stability (2000) (6)
Structural modification of c-abl in lymphoma and leukemia. (1986) (5)
PERSPECTIVES in the Literature (2000) (5)
Dual roles of ATM in the.cellular se to radiation and m cell respon control (1996) (5)
Cell-Matrix Adhesion (2000) (5)
Biomembranes and the Subcellular Organization of Eukaryotic Cells (2000) (5)
BUD 13 Promotes a Type I Interferon Response by Countering Intron Retention in Irf 7 Graphical Abstract Highlights (2018) (5)
Molecular genetics of poliovirus. (1984) (5)
The boldness of philanthropists (2016) (5)
Molecular Structure of Genes and Chromosomes (2000) (5)
Recombinant DNA and Genomics (2000) (5)
Effect ofPactamycin on Synthesis ofPoliovirus Proteins: a MethodforGenetic Mapping (1971) (5)
Programmed Delayed Splicing: A Mechanism for Timed Inflammatory Gene Expression (2018) (5)
Cellular Energetics: Glycolysis, Aerobic Oxidation, and Photosynthesis (2000) (5)
Science under Scrutiny (1990) (5)
Characterization of Abelson murine leukemia virus isolates differing in P120 expression. (1980) (5)
IN VITRO LYMPHOID CELL TRANSFORMATION BY ABELSON MURINE LEUKEMIA VIRUS (1976) (4)
Distribution of endogenous murine leukemia virus DNA sequences among mouse chromosomes (1980) (4)
Steering a Course to an AIDS Vaccine (2002) (4)
Morphogenesis of poliovirus 3. Formation of provirion in cell-free extracts. (1973) (4)
Oncogenic Mutations Affecting Cell Proliferation (2000) (4)
"Potential Biohazards of Recombinant DNA Molecules" [Letter to the Editor of Science] (1974) (4)
Limiting science: a biologist's perspective (2005) (4)
Microscopy and Cell Architecture (2000) (4)
Sixty Years of Discovery. (2019) (4)
Synthesis by reverse transcriptase of DNA complementary to globin messenger RNA. (1974) (4)
In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences (1987) (4)
Characterization of the Abelson murine leukemia virus-encoded tyrosine-specific protein kinase. (1983) (4)
Regulatory Sequences in Eukaryotic Protein-Coding Genes (2000) (4)
Interaction and Regulation of Signaling Pathways (2000) (4)
Genetic Analysis in Cell Biology (2000) (4)
Constructing DNA Libraries with λ Phage and Other Cloning Vectors (2000) (4)
Oncogenes. The beginning of the molecular description of a cancer. (1986) (4)
The Molecules of Life (2000) (3)
Stepwise Formation of Proteins on Ribosomes (2000) (3)
Kinesin, Dynein, and Intracellular Transport (2000) (3)
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products (2018) (3)
Replicative Intermediate RNAs of Poliovirus Covalent Linkage of a Protein to a Defined Nucleotide Sequence at the 5'-Terminus of Virion and (2006) (3)
Modular Binding Domains in Signal Transduction Proteins Review (1995) (3)
The Life Cycle of Cells (2000) (3)
Viability of cells in ethanol. Role of alcohol dehydrogenase. (1976) (3)
Functional Design of Proteins (2000) (3)
Growth of Microorganisms in Culture (2000) (3)
Viruses, Viruses, Viruses (2004) (3)
Lentiviral Vector- Mediated Delivery of si/ shRNA (2004) (3)
STUDIES ON POLIOVIRUS PRODUCED BY TRANSFECTION WITH CLONED VIRAL cDNA (1982) (3)
Normal and Transforming N-Terminal Variants of c- abl (1986) (3)
Developmental regulation of the TCR alpha delta locus. (1989) (3)
Function in a Human Melanoma Model MHC Class I-Restricted Cytolytic Effector TCR Synthesize Th 1 Cytokines and Exhibit MHC Class I-Restricted Epitope-Specific T Cells Transduced to Express − CD 25 + CD 4 Baltimore and Bijay Mukherji (2008) (3)
Avian Myeloblastosis Virus DNA Polymerase (1973) (3)
through the NF-kappa B transcription factor. Activation of interleukin-6 gene expression (2013) (3)
Muscle: A Specialized Contractile Machine (2000) (3)
Science for the Globe (2008) (3)
Morphology and Functional Elements of Eukaryotic Chromosomes (2000) (3)
T Cell Immunotherapy: Optimizing Trial Design (2014) (3)
Cotransport by Symporters and Antiporters (2000) (3)
DNA Microarrays: Analyzing Genome-Wide Expression (2000) (3)
AnRNA Sequence ofHundreds ofNucleotides atthe5'Endof Poliovirus RNA IsInvolved inAllowing Viral Protein Synthesis (1988) (3)
Thinking about Howard Temin. (1995) (3)
Gene Replacement and Transgenic Animals (2000) (3)
Regulation of the Eukaryotic Cell Cycle (2000) (3)
Purifying, Detecting, and Characterizing Proteins (2000) (3)
Dr Baltimore says "sorry" (1991) (3)
Activation Energy and Reaction Rate (2000) (3)
Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma (2010) (3)
Molecular Mechanisms of Eukaryotic Transcriptional Control (2000) (3)
A Nuclear Tyrosine Kinase Becomes a Cytoplasmic Oncogene a (1995) (3)
Translation of poliovirus mrna in mammalian cell-free systems. Abstr. (1973) (3)
Genetic Mapping of Mutations (2000) (3)
Open letter to Paul Doty (1991) (3)
Molecular Analysis of Photosystems (2000) (3)
Why We Need a Summit on Human Gene Editing (2016) (3)
Renato Dulbecco (1914–2012) (2012) (2)
Pi, a pre-B-cell-specific enhancer element in the immunoglobulin heavy-chain enhancer (1993) (2)
Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. (1992) (2)
Reversal of information flow in the growth of RNA tumor viruses. (1971) (2)
Identifying, Analyzing, and Sequencing Cloned DNA (2000) (2)
Cell Death and Its Regulation (2000) (2)
Will cloning beget disaster? (1997) (2)
Erratum: Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells (Cell Death and Differentiation (2012) 19 (1892) DOI: 10.1038/cdd.2012.116) (2012) (2)
Durable Suppression of Established Transmitted Founder Replication in Infected BLT Humanized Mice by Vectored ImmunoTherapy (2014) (2)
Dual expression of lambda genes in the MOPC-315 plasmacytoma. (1981) (2)
Structure and function of the Abelson murine leukemia virus transforming gene. (1983) (2)
T cell antigen discovery using signaling and antigen presenting bifunctional receptors (SABRs) (2018) (2)
The Preoccupations of Twenty-First-Century Biology (2008) (2)
The Berg letter: certainly necessary, possibly good. (1980) (2)
Can Some Knowledge Simply Cost Too Much (1975) (2)
Hematopoietic stem/progenitor cells engineered with T cell receptors for immunotherapy for HIV infection (2018) (2)
Bacterial Gene Control: The Jacob-Monod Model (2000) (2)
Production of helper-free retroviruses by transient transfection with a high titer (1994) (2)
MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells (P4467) (2013) (2)
Proceedings: Defective interfering particles. (1975) (2)
Retraction. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. (2009) (2)
Synthesis by Lymphoid Cells Transformed in Vitro by Abelson Murine Leukemia Virus (1979) (2)
Recombination between Homologous DNA Sites (2000) (2)
Bacterial Transcription Initiation (2000) (2)
Smallpox virus stocks. (1994) (2)
The Sudden Death of a Coral Reef - Response (2004) (2)
Baltimore declares O'Toole mistaken (1991) (2)
Activation of NF-kappa B precursor. (1989) (2)
Human Immunodeficiency Virus Tat-Activated Expression of Poliovirus Protein 2 A Inhibits (2)
Segment B Lymphocyte-Specific Protein Binding near an Immunoglobulin kappa-Chain Gene J (2)
Cell Interactions in Development (2000) (2)
The DNA Replication Machinery (2000) (2)
Howard Temin (1934–1994): The fierce scholar (1994) (1)
The Imanishi-Kari affair. Baltimore declares O'Toole mistaken. (1991) (1)
David Baltimore's mea culpa (1991) (1)
Mutations Causing Loss of Cell-Cycle Control (2000) (1)
Sensitive, Non‐Destructive Detection and Analysis of Neoantigen‐Specific T Cell Populations from Tumors and Blood (2018) (1)
Animal Virology. ICN-UCLA Symposia on Molecular and Cellular Biology, Vol. IV. (1976) (1)
Signal-Mediated Transport through Nuclear Pore Complexes (2000) (1)
Bridging the Science-Law Divide (2018) (1)
On the specificity of BET-1 antibody (1989) (1)
miR-146a regulates hematopoietic stem cell maintenance and cell cycle entry (2013) (1)
The Gerhard Domagk Lecture. Transcription factors in lymphoid development. (1993) (1)
reply: Investigating T-cell memory (2000) (1)
The "sunday seminar". (1976) (1)
Plea to the scientific community. (1982) (1)
Molecular Properties of Voltage-Gated Ion Channels (2000) (1)
A new genetics of poliovirus (1982) (1)
Golgi and Post-Golgi Protein Sorting and Proteolytic Processing (2000) (1)
Activation and regulation of immunoglobulin synthesis in malignant B cells/ David Baltimore ... [et al.] (1979) (1)
A Moral Duty (1968) (1)
Involvement ofa SecondLymphoid-Specific Enhancer Element in theRegulation ofImmunoglobulin Heavy-Chain GeneExpression (1990) (1)
Synthesis and Targeting of Mitochondrial and Chloroplast Proteins (2000) (1)
Pleas for would-be emigrés (1984) (1)
Polymerase Chain Reaction: An Alternative to Cloning (2000) (1)
Universities in the marketplace - The commercialization of higher education [Book Review] (2003) (1)
Avian myeloblastosis virus DNA polymerase: initiation of DNA synthesis and an associated ribonuclease. (1973) (1)
Morphogenesis ofpoliovirus III. Formation ofProvirion inCell-Free Extracts (1973) (1)
Improving anti-tumor immunity by engineering T cell receptors to prevent mispairing (VAC7P.1033) (2015) (1)
miR-146 in podocytes and diabetic injury 1 Absence of miR-146 a in Podocytes Increases Risk of Diabetic Glomerulopathy via Upregulation of ErbB 4 and Notch-1 (2016) (1)
The challenges of an HIV vaccine enterprise - Response (2004) (1)
David Baltimore Responds (1989) (1)
Mechanism ofLeukemogenesis Induced byMinkCell Focus-Forming MurineLeukemia Viruses (1991) (1)
Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer (1987) (1)
Pillars article: the V(D)J recombination activating gene, RAG-1. 1989. (2008) (1)
Smallpox Virus Stocks (1994) (1)
CHROMOSOMAL LOCATION OF STRUCTURAL GENES (1981) (1)
Synthesis and Targeting of Peroxisomal Proteins (2000) (1)
DNA polymerases in lymphoid cells. (1974) (1)
Identification and Purification of Cell-Surface Receptors (2000) (1)
Requirement for Mammalian Transcription Factor IID Transcriptional Activation by SP1 as Directed Through TATA or Initiator: Specific (2006) (1)
MiR-125b potentiates macrophage activation1 (2011) (1)
Transcription Factors in Lymphoid Development a (1993) (1)
Abelson murine leukemia virus-induced transformation of immature lymphoid cells. (1981) (1)
Erratum: An inducible transcription factor activates expression of human immunodeficiency virus in T cells (Nature (1987) 326 (711-713)) (1990) (1)
Regulation of mRNA Processing (2000) (1)
Molecular Definition of a Gene (2000) (1)
Vaccine trial provided valuable information (2008) (1)
The Recombination Activating Gene and Lymphoid Differentiation (1989) (1)
Molecular Mechanisms for Regulating Mitotic Events (2000) (1)
Lennart Philipson (1929–2011): A Warrior Has Passed (2011) (1)
The living world (2002) (1)
A SCINTILLATION PROXIMITY ASSAY (SPA) TO QUANTITATE Src HOMOLOGY 2 (SH2) AND Src HOMOLOGY 3 (SH3) DOMAIN BINDING TO SPECIFIC PEPTIDE SEQUENCES (2001) (1)
Trogocytosis-based cell platform for TCR ligand discovery (2019) (1)
by Bach1/HO-1 pathway in mice Regulation of APC development, immune response, and autoimmunity (2014) (1)
Chromosomal Organization of Genes and Noncoding DNA (2000) (1)
Gene Control in Development (2000) (1)
Investigating T-cell memory (2000) (1)
Table 15-1, Typical Ion Concentrations in Invertebrates and Vertebrates (2000) (0)
Specificity NF-kappa B Protein Purification from Bovine Spleen: Nucleotide Stimulation and Binding Site (2006) (0)
Anteroposterior Specification during Embryogenesis (2000) (0)
IdProteins IdlandId2Selectively Inhibit DNA Binding byOne ClassofHelix-Loop-Helix Proteins (1991) (0)
Figure 3-3, The peptide bond (2000) (0)
Trajectories from Snapshots: Integrated proteomic and metabolic single-cell assays reveal multiple independent adaptive responses to drug tolerance in a BRAF-mutant melanoma cell line (2019) (0)
Polyadenylic Acidon Poliovirus RNA III.InVitro Addition ofPolyadenylic AcidtoPoliovirus RNAs (1975) (0)
Abstract 2144: A novel method for high-throughput discovery of neo-antigens and corresponding T-cell receptors (2017) (0)
The abl gene and cellular transformation (1992) (0)
MicroRNA-146a Deficiency Leads to Increased Myeloid Cell Proliferation and Activation (2011) (0)
References and Notes (2021) (0)
Skewing the Playing Field: A Single-Molecule Study on how RSS Sequence Influences Gene Segment Selection (2018) (0)
Regulation of the LY-6CHI Monocyte Response by MIR-146A (2012) (0)
Npgrj_Nbt_1390 326..334 (2008) (0)
All I want for 2005 is... (2004) (0)
Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes ( antigen recognition / viral immunity / temperature-sensitive mutants / cell surface antigens ) (2003) (0)
Legal aids: Science primers in the courtroom. (2016) (0)
California Institute of Technology Annual Report, 2004-2005 (2005) (0)
Figure 19-41, Microtubule dynamics during mitosis (2000) (0)
Figure 9-22, Schematic model of an IgG antibody molecule showing its domain structure (2000) (0)
The Haiku and the Double Helix ‐ Fall 2004 (2008) (0)
Science for life: a conversation with Nobel laureate David Baltimore. Interview by Barbara J Culliton. (2006) (0)
Role of T cell receptors in suppressing HIV infection in elite controllers (2016) (0)
Plea to the Scientific Community (1982) (0)
Should the Endless Frontier of Federal Science be Expanded? (2021) (0)
Cancer Congress in Argentina (1977) (0)
Cells and Organisms (2019) (0)
Legal aids: Science primers in the courtroom (2016) (0)
Uniporter-Catalyzed Transport (2000) (0)
Letter from David Baltimore to Edwin C. Whitehead, Whitehead Associates, Inc. (1980) (0)
The change in bone size of two strains of mice over a period of 400 days of aging. (1955) (0)
Letter from David Baltimore, Whitehead Institute to Harold Varmus (1986) (0)
Fibroblast and Lymphoid Cells Identification of an Abelson Murine Leukemia Virus-Encoded Protein Present in Transformed (0)
Cancer congress in Argentina. (1977) (0)
POLIOVIRUS DOUBLE-STRANDED RNA: ITS EXISTENCE AND ROLE IN REPLICATION (1966) (0)
THE GERHARD DOMAGK LECTURE (1993) (0)
Letter from David Baltimore to Fred C. Ikle (1975) (0)
Mechanism of RNA Recombination in liovirus (2007) (0)
1964 Gordon Research Conference on Nucleic Acids (2008) (0)
What Are the Implications for Training at the Doctoral Level (2009) (0)
California Institute of Technology Annual Report 1999-2000 (1992) (0)
Annual Report 2000-2001, California Institute of Technology (2002) (0)
Disease Progression Independently of the Numbers of CD4 Human Immunodeficiency Virus Type 1 mRNA Expression in Peripheral Blood Cells Predicts (2006) (0)
Inversion for gene construction. (1986) (0)
Mechanism ofRNA Primer RemovalbytheRNaseH Activity of AvianMyeloblastosis Virus Reverse Transcriptase (1984) (0)
A Capital Campaign: An Open letter (1984) (0)
Correction: Life Iself (1997) (0)
Genetic scaremongering (1978) (0)
1997 Rhône-Poulenc Science Book Prize (1997) (0)
QnAs with David Baltimore. Interview by Prashant Nair. (2011) (0)
Figure 5-13, Phase contrast and Nomarski optics (2000) (0)
An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses (2017) (0)
In Dreams Of Yesterday (0)
Figure 7-12, Construction of a genomic library of human DNA in a bacteriophage λ vector (2000) (0)
Baltimore, Dr. David -- 1981-89 -- Correspondence, Individual -- letter, 1989-12-08 (1989) (0)
The origins of life (2002) (0)
David Baltimore (1938– ) (2018) (0)
Figure 13-1, The fate of a single parental chromosome throughout the eukaryotic cell cycle (2000) (0)
An interview with David Baltimore by Errol C. Friedberg. (2008) (0)
Elucidating the temporal dynamics of NF-κB activation by TNF-α in melanoma (2013) (0)
Hamster Leukemia Virus: LackofEndogenous DNA Synthesis andUniqueStructure ofItsDNA Polymerase (1974) (0)
Figure 2-25, The ATP cycle (2000) (0)
“The World's Most Extensive Investigation of a Scientific Paper” (1989) (0)
Producing High Levels of Proteins from Cloned cDNAs (2000) (0)
War Through the Back Door - Summer 2003 (2008) (0)
Abstract 4839: Adoptive cell transfer of transgenic T cells elicited a two-wave antitumor cellular immune response consisted of engineered and endogenous T lymphocytes with different sets of functions (2012) (0)
Molecular immunology: growth into adolescence (1984) (0)
selective introduction of genes for dendritic cell vaccination (2007) (0)
Myeloid cell-targeted miR-146a mimic alleviates NF-κB-driven cytokine storm without interfering with CD19-specific CAR T cell activity against B cell lymphoma (2019) (0)
Degrees Revoked in Soviet Union (1982) (0)
Specifitacy Test Anti-Prostaglandin F2a indirect Elisa Method (2009) (0)
rna-virus sequences cdna representierende. (1982) (0)
In Memoriam: Howard Temin, the Fierce Scholar a (1995) (0)
Scientists in the Age of Terror and Knowledge Economies (2003) (0)
Science & the Legal System (2018) (0)
An interview with David Baltimore. [Interview by Joseph Glorioso and Jenny Jacoby]. (2005) (0)
Correction: Who Gave Pinta to the Santa Maria? Tropical Diseases in a Temperate Climate (1997) (0)
Author Index to Volume 228, April-June 1985 (1985) (0)
Limits of Scientific Inquiry (1979) (0)
Degrees revoked in soviet union. (1982) (0)
AIDS agreement (1987) (0)
Technologies for personalizing cancer immunotherapies (2017) (0)
Figure 23-5, Early embryogenesis of the frog Xenopus laevis (2000) (0)
Figure 11-19, The spliceosomal splicing cycle (2000) (0)
Granulocytosis and Lymphopenia After Adoptive Transfer of NF-κB Deficient Fetal Liver Cells. • 661 (1997) (0)
Hematopoietic Stem Cells Respond Heterogeneously to Inflammatory Signals in an Age-Dependent Manner (2016) (0)
Tissue Patterning by Hedgehog and Wingless (2000) (0)
Figure 12-17, Molecular model for the catalytic activity of E. coli topoisomerase II (DNA gyrase) (2000) (0)
Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. (1989) (0)
AIDS Cure Is Far Off (2008) (0)
Abstract 19582: Deletion of miRNA-146a Alters Host Immune Response to Coxsackievirus B3 with Activation of NK cells (2012) (0)
1 The Treasure Under the Right Stone (1993) (0)
TheLongTerminal RepeatIsNota MajorDeterminant ofthe Cellular Tropism ofHumanImmunodeficiency VirusType1 (1991) (0)
The effect of the W-locus on the blood picture of old mice. (1955) (0)
RNA'S AS TEMPLATES FOR THE VIRION DNA POLYMERASE (1972) (0)
WORKSHOP SUMMARY: CELL GENES AND VIRAL TRANSFORMATION (1980) (0)
Figure 19-24, Model of kinesin-catalyzed anterograde transport (2000) (0)
Figure 19-30, Electron micrograph of two doublet microtubules in a protease-treated axoneme incubated with ATP (2000) (0)
Murine Leukemia Viruses Effect of Fv-1 Gene Product on Proviral DNA Formation and Integration in Cells Infected with (2006) (0)
Retroviruses and cancer. (1978) (0)
Adnc representant des sequences virales arn (1982) (0)
Figure 16-22, The structure of coenzyme Q (CoQ), also called ubiquinone, illustrating its ability to carry two protons and two electrons (2000) (0)
Cyclic cell state transition is associated with the adaptive resistance to BRAF inhibition in melanomas (2018) (0)
Figure 19-55, Fluorescent micrograph of a PtK2 fibroblast stained with anti-keratin antibodies (2000) (0)
Fluorescence-Activated Flow Sorting of Metaphase Chromosomes Isolation of Amplified DNA Sequences from IMR-32 Human Neuroblastoma Cells: Facilitation by (2006) (0)
New technology in immunology (WS-063) Chairpersons: Hiroyuki Kishi, Christopher Parish (2010) (0)
Reduction of caveolin and caveolae in oncogenically (2016) (0)
Biochemical Studies with Oocytes, Eggs, and Early Embryos (2000) (0)
Genetic Studies with S. pombe (2000) (0)
1478 A phase I study of personalized adoptive TCR T cell therapy in patients with solid tumors: safety, efficacy, and T cell trafficking to tumors of non-virally gene edited T cells (2022) (0)
Introduction (1999) (0)
adhesion molecule-1 up-regulatio (2016) (0)
Figure 16-15, Oxidation of fatty acids by peroxisomes (2000) (0)
Molecular Mechanisms of Responses to Morphogens (2000) (0)
Erratum for the Research Article: “Activation of the Transcriptional Function of the NF-κB Protein c-Rel by O-GlcNAc Glycosylation” by P. Ramakrishnan, P. M. Clark, D. E. Mason, E. C. Peters, L. C. Hsieh-Wilson, D. Baltimore (2014) (0)
The Quest for a Universal Flu Vaccine (2019) (0)
234: Evidence of impaired T regulatory response in preeclampsia (2009) (0)
T cell antigen discovery via signaling and antigen-presenting bifunctional receptors (2019) (0)
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission (2014) (0)
Author Correction: An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses (2018) (0)
Figure 17-40, The mannose 6-phosphate (M6P) pathway, the major route for targeting lysosomal enzymes to lysosomes (2000) (0)
Figure 7-6, Fragments produced by cleavage of the ≈36-kb DNA genome from adenovirus 2 (Ad2) by EcoRI and another restriction enzyme, HindIII from Haemophilus influenzae. (2000) (0)
T cell antigen discovery via trogocytosis (2019) (0)
The RNA tumour virus DNA polymerase: study of the endogenous and exogenous reactions. In: strategy of the viral genome. (2008) (0)
TTTACCAAAA CCCCCTCACA CTCACCTATA TTCCTCTCTC AATCTACTTT CAATCATAAA CATTATTTTC ATTTTTCTTA CTCAAATCTC TATCTTATCT TTTACTTATC 1849 1850 TCAATTAACT CCTCTTCTCA TTTATTCTTA ACTATAACTA TTCTAATCTC TCTTTTTTAA CATCTTATCC AGGAATGTCT TAAATCACAA ATCTTATACA CTTTTCCATT 1959 1960 AACCATATCA GTCATAAACT ATACAACTCT TACAT (2015) (0)
Past Virus : Unexpected Rewards from the Reconstruction of the 1918 Influenza (2012) (0)
Overview of Neuronal Outgrowth (2000) (0)
Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes (acquired immunodeficiency syndrome/polymerase chain reaction/3'-azido-3'-deoxythymidine) (2016) (0)
Figure 7-37, Two-step expression vector system based on bacteriophage T7 RNA polymerase and T7 late promoter (2000) (0)
Figure 21-6, A highly schematic diagram of the vertebrate nervous system (2000) (0)
Function of the preT-cell receptor a chain in T-cell development and allelic exclusion at the T-cell receptor f 8 locus ( gene targeting / T-cell differentiation / allelic exclusion ) (2005) (0)
Method for the expression of molecules small RNA within a cell (2002) (0)
Abstract IA1: Physiological and pathological functions of microRNAs (2012) (0)
A persistent HBV infection features spontaneous cccDNA loss and new rounds of infection (2022) (0)
Table 19-3, Primary Intermediate-Filament Proteins in Mammals (2000) (0)
ABELSON MURINE LEUKEMIA-VIRUS AND HELPER VIRUS INTERACTION WITH DIFFERENTIATED CELLS (1978) (0)
MicroRNA-125b Represses IRF4 to Induce Acute Myeloid Leukemia (2014) (0)
DNA Polymerase (Reverse Transcriptase) Specific Binding of Tryptophan Transfer RNA to Avian Myeloblastosis Virus RNA-Dependent (2006) (0)
POLIOVIRUS DOUBLE-STRANDED RNA:**Supported by funds from U. S. Public Health Grant CA-07592. ITS EXISTENCE AND ROLE IN REPLICATION (1966) (0)
564: Pregnancy primes maternal regulatory T cell response to fetal male antigen (2008) (0)
Figure 16-39, Light-harvesting complexes from the photosynthetic bacterium Rhodopseudomonas acidophila (2000) (0)
Truth buried in history (1997) (0)
T Cell Receptor Immunotherapy Drives Human Immunodeficiency Virus Evolution in Humanized Mice (2019) (0)
Cell-Type Specification in Animals (2000) (0)
Figure 14-23, Formation of the blastula during early embryogenesis in Drosophila (2000) (0)
Figure 5-20, Scanning electron micrograph of a tendon located within the shoulder of a 29-year-old male (2000) (0)
Inhibitors on Its Production Poliovirus-Induced RNA Polymerase and the Effects of Virus-Specific (0)
Figure 19-34, The stages of mitosis and cytokinesis in an animal cell (2000) (0)
Author response: MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice (2013) (0)
Challenge of the New Century: Finding an AIDS Vaccine (2004) (0)
1146 THE EFFECTS OF BROADLY NEUTRALIZING ANTIBODIES IN EXPERIMENTAL HCV INFECTION (2013) (0)
microRNA-132 regulates hematopoietic stem cell function and survival through FOXO3a (HEM5P.226) (2015) (0)
Directional Control of Neuronal Outgrowth (2000) (0)
ThePromoter oftheHumanInterleukin-2 GeneContains Two Octamer-Binding Sites andIsPartially Activated bythe Expression ofOct-2 (1990) (0)
Reciprocal and Lateral Inductive Interactions (2000) (0)
Evolution: At the Core of Molecular Change (2000) (0)
Use of Pseudotypes of Vesicular Stomatitis Virus to Study Cellular Resistance to Murine Rna Tumor Viruses (1975) (0)
Testing Yourself on the Concepts (2000) (0)
Protective effects of monomeric and dimeric forms of the 2G12 neutralizing antibody against HIV-1 infection in a modified humanized mouse model (45.28) (2010) (0)
Properties and Origin of the Subunits of Reverse Transcriptase Isolated from Avian RNA Tumor Viruses (1975) (0)
dependence in a lymphoid cell line. Abelson virus abrogation of interleukin-3 (2013) (0)
Unexpected rewards from reconstructing the 1918 influenza virus (2013) (0)
CHARACTERIZATION AND GENETIC ANALYSIS OF RETROVIRUS MATURATION: A ROLE FOR Pr180gag-pol1 (1980) (0)
Determination of the hypostatic genes in ND/EMV, RFM, MA/JAX, and SWR. (1955) (0)
Dorsoventral Patterning by TGFβ-Superfamily Proteins (2000) (0)
Organizing Cellular DNA into Chromosomes (2000) (0)
Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection (2015) (0)
Figure 11-10, Structure of complex between an RNP motif from U1A protein and RNA (2000) (0)
Methode d'expression de gene inductible (1987) (0)
B lymphocytes. broadly neutralizing anti-HIV antibody after in vitro maturation to human Engineering human hematopoietic stem/progenitor cells to produce a (2009) (0)
MicroRNA-146 targets novel signaling pathway in endothelialactivation (2014) (0)
The microRNA-212/132 cluster regulates B cell development by setting a threshold for Sox4 expression (2016) (0)
MCAT/GRE-Style Questions (2000) (0)
Supplementary Information for “Sequence-Dependent Dynamics of Synthetic and Endogenous RSSs in V(D)J Recombination” (2020) (0)
with Human Immunodeficiency Virus Type 1 Blocked Early-Stage Latency in the Peripheral Blood Cells of Certain Individuals Infected (2006) (0)
Nucleic Acid Synthesis (2000) (0)
Enigmas of filterable, invisible entities (1979) (0)
Methods used in the Assignments of the 1H and 15N resonances of the c-Abl src homology 2 (SH2) domain (1994) (0)
MicroRNA-155 Promotes Myeloid Proliferation and Is Overexpressed in Acute Myeloid Leukemia. (2007) (0)
SESSION IV Molecular Genetics of Poliovirus (1984) (0)
A MicroRNA-mediated feedback loop controls vascular inflammatory signaling (2014) (0)
Gene expression of Abelson murine leukemia virus. (1980) (0)
Figure 5-45, Electron micrograph of a mitochondrion in a section from bat pancreas (2000) (0)
Targeting Lentivectors to CD34+ Hematopoietic Stem Cells for Gene Therapy (2006) (0)
Myelo- and lympho-proliferative disorders (WS-035) Chairpersons: Nagahiro Minato, Gilbert Faure (2010) (0)
Liposome Encapsulation ofRetrovirus AllowsEfficient Superinfection ofResistant CellLines (1984) (0)
Abstract 6585: Systems biology for investigating drug resistance mechanism of melanoma (2020) (0)
Engineering Immunity against HIV - a Stem Cell Vaccine (132.12) (2009) (0)
ActivationMicroRNA-125b Potentiates Macrophage (0)
Molecular Cloning of Genes Defined by Mutations (2000) (0)
Other Mechanisms of Post-Transcriptional Control (2000) (0)
Figure 5-23, Cell fractionation by differential centrifugation (2000) (0)
transmission of HIV in humanized mice Inhibitory effect of HIV-specific neutralizing IgA on mucosal (2012) (0)
ABELSON VIRUS LYMPHOID CELL TRANSFORMATION ASSAY Materials and Methods Cell Preparation (2003) (0)
Terminal Deoxynucleotidyl Transferase in a Case of Childhood Acute Lymphoblastic Leukemia ( thymocytes / DNA polymerases ) (0)
the segment encoding protein-tyrosine kinase. The minimum transforming region of v-abl is (2013) (0)
HIV-1 Nef proteinprotects infectedprimarycells against killingby cytotoxicT lymphocytes (0)
Lymphocytes + Disease Progression Independently of the Numbers of CD 4 Human Immunodeficiency Virus Type 1 mRNA Expression in Peripheral Blood Cells Predicts (2004) (0)
on Transcriptional Elongation The Role of Tat in the Human Immunodeficiency Virus Life Cycle Indicates a Primary Effect (2006) (0)
The Diversion of Macromolecular Synthesis in L-Cells Towards Ends Dictated by Mengovirus (2019) (0)
Manipulating Cells and Viruses in Culture (2000) (0)
Figure 12-23, Formation of a spontaneous point mutation by deamination of cytosine (C) to form uracil (U) (2000) (0)
Other Transcription Systems (2000) (0)
a rel-Related Polypeptide (1991) (0)
Système de culture de lymphopoïèse de lymphocytes b humains in vitro (2009) (0)
CO2 Metabolism during Photosynthesis (2000) (0)
Figure 15-9, Transmembrane forces acting on Na+ ions (2000) (0)
Analyzing Specific Nucleic Acids in Complex Mixtures (2000) (0)
Line Regulated Expression of an Immunoglobulin kappa Gene Introduced into a Mouse Lymphoid Cell (0)
Pregnancy primes an antigen specific maternal regulatory T cell response to fetal male antigen (33.6) (2009) (0)
Efﬁcient Gene Targeting Mediated by Adeno-Associated Virus and DNA Double-Strand Breaks (2003) (0)
fi ciency of Nuclear Factor-k B c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice (2016) (0)
Artificial Thymic Organoids Permit Allelic Exclusion and Efficient Generation of Naïve TCR-Engineered T-Cells from Human Hematopoietic Stem Cells In Vitro (2016) (0)
Virus Synthesis of a 600-Nucleotide-Long Plus-Strand DNA by Virions of Moloney Murine Leukemia (0)
Abstract IA17: Technologies for personalizing cancer immunotherapies (2017) (0)
by Cytotoxic T Lymphocytes Vesicular Stomatitis Virus Glycoprotein is Necessary for H-2-Restricted Lysis of Infected Cells (2003) (0)
Purification and expression of an Abelson-murine-leukaemia-virus-encoded protein kinase from Escherichia coli (1984) (0)
Formation of Topographic Maps and Synapses (2000) (0)
Figure 6-12, Structure of picornaviruses (2000) (0)
Single Cell Proteomics Reveals Novel Cytokine-Producing Function of Hematopoietic Stem and Progenitor Cells (2012) (0)
Requirement and Template Specificity of the DNA Polymerase of RNA Tumor Viruses (0)
A process for the expression of small antiviral RNA molecules within a cell (2002) (0)
Cell-Type Specification and Mating-Type Conversion in Yeast (2000) (0)
Cells into Tissues (2000) (0)
Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line (2020) (0)
mRNA stability influences the temporal order of inflammatory gene induction (136.1) (2009) (0)
CHARACTERIZATION AND GENETIC ANALYSIS OF RETROVIRUS MATURATION: A ROLE FOR Pr180 gag-pol 1 (1980) (0)
Studies of immunodifferentiation using transgenic mice. (1985) (0)
Characterization ofEndonuclease Activities inMoloney Murine Leukemia VirusandItsReplication-Defective (1987) (0)
Infection of Lymphocytes and Monocytes Kinetics of Expression of Multiply Spliced RNA in Early Human Immunodeficiency Virus Type (0)
Figure 7-17, Membrane-hybridization assay for detecting nucleic acids (2000) (0)
The Architecture of Cells (2000) (0)
PS2-083 Immunization with a novel dc-targeting lentiviral vector induces polyfunctional cd8 t cell responses and therapeutic anti-tumor immunity (2011) (0)
MicroRNAs in immune development/responses (WS-062) Chairpersons: Ken Ishii, Taro Fukao (2010) (0)
Vectored ImmunoProphylaxis with VRC07 Protects BLT Humanized Mice from Vaginal Transmission of Founder HIV (2013) (0)
Poliovirus-Infected Cells Genome-Linked Protein VPg of Poliovirus is Present as Free VPg and VPg-pUpU in (2006) (0)
Eukaryotic Gene Control: Purposes and General Principles (2000) (0)
Figure 13-27, Assembly of the pre-replication complex and its regulation by Cdc28 – Clb (Cdk – cyclin B) complexes in S. cerevisiae. (2000) (0)
Figure 4-30, Recognition of a tRNA by aminoacyl synthetases. Aspartyl-tRNA synthetase (AspRS) is a class II enzyme, and arginyl-tRNA synthetase (ArgRS) is a class I enzyme (2000) (0)
Specification of Floral-Organ Identity in Arabidopsis (2000) (0)
Supplementary Information for ”Probing the Sequence-Dependent Dynamics of Synthetic and Endogenous RSSs in V(D)J Recombination” (2019) (0)
Single Molecule Dynamics Governing the Initiation of V(D)J Recombination (2014) (0)
Table 17-5, ABO Blood Groups (2000) (0)
95. Transduction and Expression of shRNAs Via Lentiviral Bectors Bearing a U6 RNA Polymerase III Promoter, but Not an H1 Promoter, Induce Elevated Apoptosis in Human Primary Peripheral Blood T Lymphocytes (2005) (0)
Poliovirus MutantThatContains a Cold-Sensitive Defect inViral RNA Synthesis (1988) (0)
Testimony by David Baltimore for the Committee on Science and Technology (1977) (0)
Genetic Studies with S. cerevisiae (2000) (0)
Coordinate activation of c-Src by SH3 and SH2-binding sites on a novel, plSO^^^-related protein, Sin (2007) (0)
Figure 7-2, Plasmid DNA replication (2000) (0)
of NF-kappaB by I kappaB. A 65-kappaD subunit of active NF-kappaB is required for inhibition (2011) (0)
Synthesis of Biopolymers: Rules of Macromolecular Carpentry (2000) (0)
PRODUCTION DE cADN REPRESENTANT DES SEQUENCES DU VIRUS DE L'HEPATITE A (1984) (0)
Figure 23-31, During development of the zebrafish embryo, growth cones of pioneer motor neurons follow different pathways (2000) (0)
infection Broadly neutralizing antibodies abrogate established hepatitis C virus (2014) (0)
Table 3. EFFECT OF RIBONUCLEASE ON THE DNA POLYMERASE ACTIVITY OE RAUSCHER MOUSE LEUKAEMIA VIRUS (1970) (0)
General Features of Chromosomal Replication (2000) (0)
PERSPECTIVES for the Future (2000) (0)
The Quest for a Cure: AIDS Research at the Millennium (1997) (0)
Functional Rearrangements in Chromosomal DNA (2000) (0)

This paper list is powered by the following services:

Other Resources About David Baltimore

What Schools Are Affiliated With David Baltimore?

David Baltimore is affiliated with the following schools:

David Baltimore's Academic­Influence.com Rankings

Why Is David Baltimore Influential?

David Baltimore's Published Works

Published Papers

Other Resources About David Baltimore

What Schools Are Affiliated With David Baltimore?

Image Attributions

David Baltimore's AcademicInfluence.com Rankings